Wednesday, March 27, 2019
ANS-Cholinergic Drugs
ANS-Cholinergic Drugs
Cholinergic Drugs
Muscarinic agonists : methacholine, carbachol, bethanechol, pilocarpine
Acetylcholine esterase inhibitors : physostigmine, neostigmine*, pyridostigmine,
edrophonium, echothiophate, malathion, parathion, paraoxonC, sarin, pralidoxime
AntiAlzheimer’s : Tacrine*, donepezil, rivastigmine
Cholinergic antagonists : Atropine, scopolamine, homatropine, ipratropium
cyclopentolate*, dicyclomine*, benztropine, procyclidine, isopropamide, tropicamide
Ganglion blockers : (Self study- 1 hr) trimethaphan, mecamylamine, hexamethonium
Neuromuscular blockers :(Self study) tubocurarine, gallamine, succinylcholine,
decamethonium
Notes
cholinergics and anticholinesterases
Drug treatment of alzheimers disease
Neuromuscular blocking agents and ganglionic blockers-converted
Cholinergic Drugs
Muscarinic agonists : methacholine, carbachol, bethanechol, pilocarpine
Acetylcholine esterase inhibitors : physostigmine, neostigmine*, pyridostigmine,
edrophonium, echothiophate, malathion, parathion, paraoxonC, sarin, pralidoxime
AntiAlzheimer’s : Tacrine*, donepezil, rivastigmine
Cholinergic antagonists : Atropine, scopolamine, homatropine, ipratropium
cyclopentolate*, dicyclomine*, benztropine, procyclidine, isopropamide, tropicamide
Ganglion blockers : (Self study- 1 hr) trimethaphan, mecamylamine, hexamethonium
Neuromuscular blockers :(Self study) tubocurarine, gallamine, succinylcholine,
decamethonium
Notes
cholinergics and anticholinesterases
Drug treatment of alzheimers disease
Neuromuscular blocking agents and ganglionic blockers-converted
ANS Drugs - Adrenergic Drugs
Adrenergic Drugs
Alpha adrenergic agonists: phenylephrine*, naphazoline, xylometazoline, oxymetazoline,
methyldopa, clonidine, guanabenz, guanafacine
Beta agonists : Isoproterenol, colterol, metaproterenol, terbutaline*, albuterol,
isoxsuprine, ritodrine
Alpha antagonist : tolazoline, phentolamine, phenoxybenzamine, prazosin, doxazosin
Beta Antagonists : pronethalol, propranolol*, pindolol, sotalol, timolol, atenolol,
metoprolol, esmolol, acebutolol, carvedilol, labetalol* (last two for self study, including
synthesis of labetalol)
Other adrenergic agents (Self study-2 hrs) : amphetamine, pseudoephedrine, ephedrine,
guanethidine, propylhexedrine, reserpine
Notes
Adrenergic Synthesis And Metabolism animation
Catecholamine Biosynthesis Pathway
mechanism of action of adrenergic receptor
Alpha adrenergic agonists: phenylephrine*, naphazoline, xylometazoline, oxymetazoline,
methyldopa, clonidine, guanabenz, guanafacine
Beta agonists : Isoproterenol, colterol, metaproterenol, terbutaline*, albuterol,
isoxsuprine, ritodrine
Alpha antagonist : tolazoline, phentolamine, phenoxybenzamine, prazosin, doxazosin
Beta Antagonists : pronethalol, propranolol*, pindolol, sotalol, timolol, atenolol,
metoprolol, esmolol, acebutolol, carvedilol, labetalol* (last two for self study, including
synthesis of labetalol)
Other adrenergic agents (Self study-2 hrs) : amphetamine, pseudoephedrine, ephedrine,
guanethidine, propylhexedrine, reserpine
Notes
Adrenergic Synthesis And Metabolism animation
Catecholamine Biosynthesis Pathway
mechanism of action of adrenergic receptor
Wednesday, March 13, 2019
Antiparkinson’s
Syllabus
carbidopa, levodopa, selegiline, amantadine, benztropine, procyclidine, orphenadrine
(last 3 drugs for self study- 1 hr)
Notes Antiparkinsons drugs
Parkinson Disease animation
Parkinson's Disease, Animation
Parkinson's Disease Treatment Mode of Action Animation
COMT Inhibitors for Parkinson's Disease
carbidopa, levodopa, selegiline, amantadine, benztropine, procyclidine, orphenadrine
(last 3 drugs for self study- 1 hr)
Notes Antiparkinsons drugs
Parkinson Disease animation
Parkinson's Disease, Animation
Parkinson's Disease Treatment Mode of Action Animation
COMT Inhibitors for Parkinson's Disease
Anxiolytics
Anxiolytics
Oxazepam, buspirone, meprobamate, tybamate (last two for self study- 1 hr)
Powerpoint Presentataion
Antipsychotics
Antipsychotics
Powerpoint Presentation for Topic
https://drive.google.com/file/d/1IkeiX_nijV0NaJgr3mQsoeWGupGxje3H/view?usp=sharing
Supporting files
VDOs
Psychopharmacology - Antipsychotics Pharmacology
Clera Antipsychotic Science
Schizophrenia Part 1 of 4 - Medical Animation by Watermark
Schizophrenia Part 2 of 4 - Medical Animation by Watermark
Schizophrenia Part 3 of 4 - Medical Animation by Watermark
Schizophrenia Part 4 of 4 - Medical Animation by Watermark
Powerpoint Presentation for Topic
https://drive.google.com/file/d/1IkeiX_nijV0NaJgr3mQsoeWGupGxje3H/view?usp=sharing
Supporting files
VDOs
Psychopharmacology - Antipsychotics Pharmacology
Clera Antipsychotic Science
Schizophrenia Part 1 of 4 - Medical Animation by Watermark
Schizophrenia Part 2 of 4 - Medical Animation by Watermark
Schizophrenia Part 3 of 4 - Medical Animation by Watermark
Schizophrenia Part 4 of 4 - Medical Animation by Watermark
Subscribe to:
Posts (Atom)